TY - JOUR
T1 - A proctoring system to manage the learning curve associated with the introduction of transcatheter aortic valve implantation in Japan
AU - On behalf of the OCEAN-TAVI Registry
AU - Yamawaki, Masahiro
AU - Iwasaki, Kiyotaka
AU - Araki, Motoharu
AU - Ito, Tsutomu
AU - Ito, Yoshiaki
AU - Tada, Norio
AU - Takagi, Kensuke
AU - Yamanaka, Futoshi
AU - Watanabe, Yusuke
AU - Yamamoto, Masanori
AU - Shirai, Shinichi
AU - Hayashida, Kentaro
N1 - Funding Information:
This research was financially supported by Edwards Lifesciences and Medtronic. Motoharu Araki, Tsutomu Ito, Norio Tada, Yusuke Watanabe, Kensuke Takagi, Masanori Yamamoto, Shinichi Shirai, and Kentaro Hayashida are proctors of Edwards Lifesciences. Yusuke Watanabe is a proctor of Medtronic. The other authors have no conflicts of interest to declare regarding this manuscript.
Funding Information:
Funding This research was financially supported by Edwards Lifes-ciencesand Medtronic.
Publisher Copyright:
© 2017, Springer Japan KK, part of Springer Nature.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - As transcatheter aortic valve implantation (TAVI) requires multidisciplinary collaboration, operators and the entire heart team must overcome a steep learning curve. A web-based screening and traditional on-site proctoring system were developed for the introduction of TAVI in Japan. To assess the learning curve involved with the introduction of TAVI under the supervision of a novel proctoring system. We divided 749 consecutive patients enrolled in the OCEAN-TAVI study between October 2013 and August 2015 into the trans-femoral (TF, n = 608) and transapical (TA, n = 141) approach groups to compare outcomes in patients who underwent TAVI during the early proctoring period (proctoring group) and after the procedures began to be performed independently (independent group). The primary endpoint was the rate of composite events regarding early safety (at 30 days) according to the valve academic research consortium-2 criteria. For TF-TAVI, the logistic EuroSCORE and the rate of peripheral artery disease were significantly lower during the independent period. The rate of device success significantly increased during the independent period (90.5 vs. 81.8%, p = 0.005). The rate of the primary endpoint was significantly reduced during the independent period compared to that during the proctoring period for TA-TAVI (21.3 vs. 37.9%, p = 0.031); however, no difference was observed for TF-TAVI (16.8 vs. 13.1%, p = 0.283). No deaths occurred within 30 days during the proctoring period for TF-TAVI. After adjustment using propensity score matching, the procedure time for TF-TAVI (88 ± 43 vs. 102 ± 36 min, p = 0.004) and the rate of life-threatening bleeding for TA-TAVI (3.6 vs. 25%, p = 0.026) reduced during the independent period compared to the values during the proctoring period. During the introduction of TAVI under the supervision of a new proctoring system in Japan, clinical outcomes and technical aspects improved significantly. There are differences in the steepness of the learning curve between TF-TAVI and TA-TAVI.
AB - As transcatheter aortic valve implantation (TAVI) requires multidisciplinary collaboration, operators and the entire heart team must overcome a steep learning curve. A web-based screening and traditional on-site proctoring system were developed for the introduction of TAVI in Japan. To assess the learning curve involved with the introduction of TAVI under the supervision of a novel proctoring system. We divided 749 consecutive patients enrolled in the OCEAN-TAVI study between October 2013 and August 2015 into the trans-femoral (TF, n = 608) and transapical (TA, n = 141) approach groups to compare outcomes in patients who underwent TAVI during the early proctoring period (proctoring group) and after the procedures began to be performed independently (independent group). The primary endpoint was the rate of composite events regarding early safety (at 30 days) according to the valve academic research consortium-2 criteria. For TF-TAVI, the logistic EuroSCORE and the rate of peripheral artery disease were significantly lower during the independent period. The rate of device success significantly increased during the independent period (90.5 vs. 81.8%, p = 0.005). The rate of the primary endpoint was significantly reduced during the independent period compared to that during the proctoring period for TA-TAVI (21.3 vs. 37.9%, p = 0.031); however, no difference was observed for TF-TAVI (16.8 vs. 13.1%, p = 0.283). No deaths occurred within 30 days during the proctoring period for TF-TAVI. After adjustment using propensity score matching, the procedure time for TF-TAVI (88 ± 43 vs. 102 ± 36 min, p = 0.004) and the rate of life-threatening bleeding for TA-TAVI (3.6 vs. 25%, p = 0.026) reduced during the independent period compared to the values during the proctoring period. During the introduction of TAVI under the supervision of a new proctoring system in Japan, clinical outcomes and technical aspects improved significantly. There are differences in the steepness of the learning curve between TF-TAVI and TA-TAVI.
KW - Heart team education
KW - Learning curve
KW - Proctoring system
KW - Transcatheter aortic valve implantation (TAVI)
UR - http://www.scopus.com/inward/record.url?scp=85037700835&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85037700835&partnerID=8YFLogxK
U2 - 10.1007/s00380-017-1098-9
DO - 10.1007/s00380-017-1098-9
M3 - Article
C2 - 29230569
AN - SCOPUS:85037700835
SN - 0910-8327
VL - 33
SP - 630
EP - 639
JO - Heart and Vessels
JF - Heart and Vessels
IS - 6
ER -